Ruoyi Bio

Shanghai, China · Founded 2018 · Privately Held (backing)

Developer of recombinant protein drug intended for synthetic biology. Ruoyi Bio is based in Shanghai, China and was founded in 2018. Its last reported valuation was $23.4 million in Mar 2022. It has raised $7.6 million.

Last reported valuation
$23.4M
Oct 2026
Priced at
—
Total raised
$7.6M
Last round
—

Who backs Ruoyi Bio?

5 investors
InvestorType
YuanBio Venture CapitalVenture capital
Kunshan Industrial Technology Research InstituteOther
Kunshan Guoke Venture CapitalOther
Alan Asset Management—
DNE Group—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ruoyi Bio investors

5 investors are on record for Ruoyi Bio, including YuanBio Venture Capital, Kunshan Industrial Technology Research Institute, Kunshan Guoke Venture Capital and Alan Asset Management.

Free account
More of Ruoyi Bio with a free account
  • ·Watch Ruoyi Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Ruoyi Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View